Table 1.

Clinical characteristics of patients treated with gefitinib

PatientAgeSexPYDisease statusLinesResponseTTF (months)OS (months)
157F0Stage IV*3PR13.848.5
248F0Stage IV1PR11.012.2
358M34Stage IV2PR14.523.7
475M0Stage IV2PR43.963.0
593F0Stage IV1PR14.830.9
662M26Stage IV2PR9.132.9

Abbreviations: PY, pack years (smoking status); TTF, time to treatment failure; OS, overall survival; PR, partial response.

  • *Postsurgical recurrence.